Cannabis Investor NewsSubscribe →
C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
— —

Turning Point Brands

—
—
Live Price

CIN RESEARCH · DATED EVIDENCE

Dated financial evidence

Turning Point Brands: revenue expanded; follow the cash evidence.

The reported-period revenue series records USD 142.96m for the period ended June 30, 2026. That is 22.6% above the same reporting basis a year earlier. Cash and operating cash flow are available on a matching dated basis.

Latest financial observation 2026-06-30Last reported price 2026-11-06Research checked 2026-11-06 13:31 UTC

The check time records a research refresh. Each financial figure and price keeps its own reporting date.

Compare like-for-like revenue

The reported-period revenue series records USD 142.96m for the period ended June 30, 2026. That is 22.6% above the same reporting basis a year earlier.

Put cash beside operating cash flow

Period-end cash was USD 268.31m at 2026-06-30. The matching reported-period operating cash inflow was USD 26.33m. Later financing and cash movements are not established by this snapshot.

Reported financial evidence

Latest retained observation for each measure. Reporting periods and currencies can differ.
MeasureReported value & unitPeriod & intervalEvidence basis
RevenueUSD 142.96mUnit: USDQuarterly seriesDated financial series
Cost of revenueUSD 49.26mUnit: USDQuarterly seriesDated financial series
Gross profitUSD 93.7mUnit: USDQuarterly seriesDated financial series
Operating incomeUSD 16.71mUnit: USDQuarterly seriesDated financial series
EBITDAUSD 20.61mUnit: USDQuarterly seriesDated financial series
Cash balanceUSD 268.31mUnit: USDBalance at period endDated financial series
Total assetsUSD 855.2mUnit: USDBalance at period endDated financial series
Total liabilitiesUSD 401.17mUnit: USDBalance at period endDated financial series
Shareholders’ equityUSD 430.1mUnit: USDBalance at period endDated financial series
Operating cash flowUSD 26.33mUnit: USDQuarterly seriesDated financial series
Free cash flowUSD 26.24mUnit: USDQuarterly seriesDated financial series

A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.

What changed against the prior year

Only the same measure, unit, reporting frequency and prior-year period end are compared. A reported change is not an investment rating.

Revenue · Quarterly series

Increased +22.6%

2025-06-30
USD 116,634,000
2026-06-30
USD 142,960,000
Cost of revenue · Quarterly series

Decreased -1.5%

2025-06-30
USD 50,011,000
2026-06-30
USD 49,256,000
Gross profit · Quarterly series

Increased +40.6%

2025-06-30
USD 66,623,000
2026-06-30
USD 93,704,000
Operating income · Quarterly series

Decreased -36.5%

2025-06-30
USD 26,327,000
2026-06-30
USD 16,713,000
EBITDA · Quarterly series

Decreased -31.6%

2025-06-30
USD 30,126,000
2026-06-30
USD 20,611,000
Cash balance · Balance at period end

Increased +144.1%

2025-06-30
USD 109,925,000
2026-06-30
USD 268,307,000
Total assets · Balance at period end

Increased +43.5%

2025-06-30
USD 595,788,000
2026-06-30
USD 855,196,000
Total liabilities · Balance at period end

Increased +8.1%

2025-06-30
USD 370,965,000
2026-06-30
USD 401,172,000
Shareholders’ equity · Balance at period end

Increased +96.8%

2025-06-30
USD 218,576,000
2026-06-30
USD 430,098,000
Operating cash flow · Quarterly series

Increased +122.7%

2025-06-30
USD 11,821,000
2026-06-30
USD 26,327,000
Free cash flow · Quarterly series

Increased +235.1%

2025-06-30
USD 7,830,000
2026-06-30
USD 26,239,000

What to investigate next

  • Resolve the conflicting financial observations against the primary report.
  • Read the latest linked company disclosures and any reporting after the financial period.
  • Check post-period financing, share issuance and changes in cash before drawing a current valuation conclusion.

Evidence boundaries

  • Conflicting observations for the same concept, period and reporting basis are withheld.
  • No dated primary company disclosures were supplied; absence in this feed is not a clean regulatory check.
  • Interim frequency is provider-classified. Generic form labels are not treated as proof of an SEC filing or a three-month reporting duration.
  • The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.

Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →

Price History · USD 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

CONTINUE YOUR RESEARCH

Connect the next piece.